AMITRIPTYLINE MARKET ANALYSIS

Amitriptyline MarketSize and Trends

Global amitriptyline market is estimated to be valued at US$ 607.0 Million in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030). An increase in product launches by the key market players is expected to drive the market growth over the forecast period. Moreover, an increase in the prevalence of anxiety and migraine is expected to drive the market growth.

Global Amitriptyline Market Segmentation:

Global amitriptyline market report is segmented into strength, indication, distribution channel and region

• Based on strength, the market is segmented into 10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, and 150 mg tablets. Out of which, the 10 mg tablets segment is expected to dominate the global amitriptyline market during the forecast period, and this is attributed to an increase in the product launched by key market players.
• Based on indication, the market is segmented into depression, nocturnal enuresis, migraine, chronic neuropathic pain, and others. Out of which, the depression segment is expected to dominate the global amitriptyline market during the forecast period, and this is attributed to an increase in the prevalence of depression globally.
• Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Out of which, the hospital pharmacies segment is expected to dominate the market over the forecast period and this is attributed to an increase in the number of hospitals and number of patient visits in hospital globally.

Among all segmentation, the distribution channel segment has the highest potential due to an increase in the number of pharmacies in the U.S. For instance, according to an article published by The Commonwealth Fund, a private U.S.-based foundation involved in providing standard health care services, in August 2021, there are roughly 60,000 retail pharmacies in the U.S., and one-third are independent pharmacies and two-thirds are retail chains, supermarkets, and mass retailers.

Global Amitriptyline Market Cross-Sectional Analysis: In the distribution channel segment, the hospitals pharmacies segment held a dominant position in the Asia Pacific region, due to an increase in the number of hospitals and hospital pharmacies in this region. For instance, according to an article published by Asian Hospital & Healthcare Management, in December 2022, there were more than 36,570 hospitals in China, in the year 2021. Thus, the rising number of hospitals will eventually increase the number of hospital pharmacies and drive the market growth.